Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1973 Dec;46(5):617–622.

MSH-release inhibiting factors: recent studies.

A J Kastin, N P Plotnikoff, S Viosca, M S Anderson, A V Schally
PMCID: PMC2592035  PMID: 4591788

Full text

PDF
617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bower A., Hadley M. E., Hruby V. J. Comparative MSH release-inhibiting activities of tocinoic acid (the ring of oxytocin), and L-pro-L-leu-gly-NH 2 (the side chain of oxytocin). Biochem Biophys Res Commun. 1971 Dec 3;45(5):1185–1191. doi: 10.1016/0006-291x(71)90143-4. [DOI] [PubMed] [Google Scholar]
  2. Celis M. E., Hase S., Walter R. Structure-activity studies of MSH-release-inhibiting hormone. FEBS Lett. 1972 Nov 1;27(2):327–330. doi: 10.1016/0014-5793(72)80651-3. [DOI] [PubMed] [Google Scholar]
  3. Celis M. E., Taleisnik S., Walter R. Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1428–1433. doi: 10.1073/pnas.68.7.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Celis M. E., Taleisnik S., Walter R. Release of pituitary melanocyte-stimulating hormone by the oxytocin fragment, H-Cys-Tyr-Ile-Gln-Asn-Oh. Biochem Biophys Res Commun. 1971 Nov 5;45(3):564–569. doi: 10.1016/0006-291x(71)90454-2. [DOI] [PubMed] [Google Scholar]
  5. Hruby V. J., Smith C. W., Bower A., Hadley M. E. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones. Science. 1972 Jun 23;176(4041):1331–1332. doi: 10.1126/science.176.4041.1331. [DOI] [PubMed] [Google Scholar]
  6. Kastin A. J., Barbeau A. Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease. Can Med Assoc J. 1972 Dec 9;107(11):1079–1081. [PMC free article] [PubMed] [Google Scholar]
  7. Kastin A. J., Miller M. C., Ferrell L., Schally A. V. General activity in intact and hypophysectomized rats after administration of melanocyte-stimulating hormone (MSH), melatonin, and PRO-LEU-GLY-NH 2 . Physiol Behav. 1973 Feb;10(2):399–401. doi: 10.1016/0031-9384(73)90330-2. [DOI] [PubMed] [Google Scholar]
  8. Kastin A. J., Schally A. V. In vivo assay for melanocyte lightening substances. Experientia. 1966 Jun 15;22(6):389–389. doi: 10.1007/BF01901154. [DOI] [PubMed] [Google Scholar]
  9. Kastin A. J., Schally A. V., Viosca S. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary. Proc Soc Exp Biol Med. 1971 Sep;137(4):1437–1439. doi: 10.3181/00379727-137-35805. [DOI] [PubMed] [Google Scholar]
  10. Lapin I. P., Oxenkrug G. F., Osipova S. V., Uskova N. V. The frog as a subject for screening thymoleptic drugs. J Pharm Pharmacol. 1970 Oct;22(10):781–782. doi: 10.1111/j.2042-7158.1970.tb08429.x. [DOI] [PubMed] [Google Scholar]
  11. Nair R. M., Kastin A. J., Schally A. V. Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity. Biochem Biophys Res Commun. 1972 Jun 28;47(6):1420–1425. doi: 10.1016/0006-291x(72)90231-8. [DOI] [PubMed] [Google Scholar]
  12. Nair R. M., Kastin A. J., Schally A. V. Isolation and structure of hypothalamic MSH release-inhibition hormone. Biochem Biophys Res Commun. 1971 Jun 18;43(6):1376–1381. doi: 10.1016/s0006-291x(71)80026-8. [DOI] [PubMed] [Google Scholar]
  13. Plotnikoff N. P., Kastin A. J., Anderson M. S., Schally A. V. DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). Life Sci I. 1971 Nov 15;10(22):1279–1283. doi: 10.1016/0024-3205(71)90326-2. [DOI] [PubMed] [Google Scholar]
  14. Plotnikoff N. P., Kastin A. J., Anderson M. S., Schally A. V. Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide. Neuroendocrinology. 1973;11(1):67–71. doi: 10.1159/000122119. [DOI] [PubMed] [Google Scholar]
  15. Plotnikoff N. P., Kastin A. J., Anderson M. S., Schally A. V. Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF). Proc Soc Exp Biol Med. 1972 Jul;140(3):811–814. doi: 10.3181/00379727-140-36558. [DOI] [PubMed] [Google Scholar]
  16. Schally A. V., Kastin A. J. Purification of a bovine hypothalamic factor which elevates pituitary MSH levels in rats. Endocrinology. 1966 Oct;79(4):768–772. doi: 10.1210/endo-79-4-768. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES